Home Knowledge Base W.H.O.

W.H.O.

No mentions found

This entity hasn't been tracked yet, or Iris is still building its knowledge base.

Related Articles from SNS

New Velociraptor cousin was a '4-winged' dragon that hunted prey from the trees of ancient China, fossil find hints

New Velociraptor cousin was a '4-winged' dragon that hunted prey from the trees of ancient China, fossil find hints A new microraptor from Cretaceous China likely preyed on ancient birds. A newly discovered feathered dinosaur with four wing-like limbs may have prowled the lakeside forests of what is now northwestern China, gliding between trees like a flying squirrel and snatching some of the earliest birds out of the Cretaceous sky. The predator, named Jian changmaensis, was a close cousin...

Live Science 5d ago

Why the Public Is Gravitating Toward the Hunter Biden Approach

This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. For some time, the Biden family standings were clear. Hunter, the ne’er-do-well son, resided in the basement.

The Atlantic 1d ago

Never Call Retreat

We tend to think we have one national anthem, but to me, we have always seemed to have two. The first is the official one, “The Star-Spangled Banner.” The second is “Battle Hymn of the Republic.”

The Atlantic 2d ago

How to Tell the American Story

Illustrations by Tyler ComrieOn a July afternoon in 2019, I found myself in a large, sun-dappled room within one of America’s great estates. An assemblage of distinguished jurists, Ivy League professors, nonprofit leaders, journalists, and theologians sat around me in a half circle. I was trying to be on my best behavior, but I blurted out a word dirty enough to make them blanch.

The Atlantic 2d ago

This drug delayed rheumatoid arthritis for years after treatment ended

This drug delayed rheumatoid arthritis for years after treatment ended - Date: - June 1, 2026 - Source: - King's College London - Summary: - A promising new study suggests rheumatoid arthritis may not be as inevitable as once thought for people at high risk. Researchers found that just one year of treatment with the immune-targeting drug abatacept delayed the onset of rheumatoid arthritis by up to four years, with benefits lasting long after treatment ended. - Share: People at high risk of...

Science Daily 9d ago